Galderma Group AG Sustainability Profile
Galderma Group AG, a leading global dermatology company, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1981, Galderma has established itself as a pioneer in the dermatological field, focusing on innovative solutions for skin health. The company is renowned for its core products, including aesthetic injectables, prescription dermatology treatments, and skincare solutions, which are distinguished by their scientific rigor and commitment to safety. Galderma's flagship brands, such as Restylane and Differin, have garnered significant market recognition, positioning the company as a trusted name in both medical and aesthetic dermatology. With a strong emphasis on research and development, Galderma continues to achieve notable milestones, solidifying its status as a key player in the global dermatology market.
DitchCarbon Score
How does Galderma Group AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Galderma Group AG's score of 37 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Galderma Group AG's reported carbon emissions
In 2023, Galderma Group AG reported total carbon emissions of approximately 332,100,000 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions accounted for about 7,600,000 kg CO2e, while Scope 2 emissions totalled approximately 5,500,000 kg CO2e (with a market-based approach reflecting 700,000 kg CO2e). Notably, the company did not disclose Scope 3 emissions data for 2022. Galderma has not set specific reduction targets or initiatives as part of its climate commitments, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi). The absence of defined reduction strategies indicates a potential area for future development in their sustainability efforts. The emissions data is not cascaded from any parent organization, and all figures are directly reported by Galderma Group AG. The company operates with a revenue of approximately USD 4.12 billion in 2023, highlighting the scale of its operations in relation to its carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 9,800,000 | 0,000,000 |
| Scope 2 | 4,200,000 | 000,000 |
| Scope 3 | - | 000,000,000 |
How Carbon Intensive is Galderma Group AG's Industry?
How Carbon Intensive is Galderma Group AG's Location?
Galderma Group AG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Galderma Group AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
